clathrin light chain binding [MF],
guanidinoacetate N-methyltransferase activity [MF],
2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [MF],
protein targeting to mitochondrion [BP]
negative regulation of Wnt receptor signaling pathway involved in digestive tract morphogenesis [BP]
N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [MF],
nicotinamide phosphoribosyltransferase activity [MF]
cholate-CoA ligase activity [MF]
beta-catenin binding [MF],
mitotic nuclear envelope reassembly [BP]
L-aspartate:2-oxoglutarate aminotransferase activity [MF],
glutamate catabolic process to aspartate [BP],
aspartate biosynthetic process [BP]
tapasin binding [MF],
protein-N-terminal asparagine amidohydrolase activity [MF],
antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent [BP],
positive regulation of antigen processing and presentation of peptide antigen via MHC class I [BP],
cytosol to ER transport [BP],
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent [BP],
TAP complex [CC],
antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent [BP],
TAP2 binding [MF],
TAP1 binding [MF],
peptide antigen-transporting ATPase activity [MF],
oligopeptide-transporting ATPase activity [MF]
external side of plasma membrane [CC],
transferrin receptor activity [MF]
(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity [MF],
cardiolipin hydrolase activity [MF]
protein-disulfide reductase activity [MF],
extracellular matrix structural constituent [MF],
cell adhesion [BP],
laminin-2 complex [CC],
laminin-8 complex [CC]
urocanate hydratase activity [MF]
glycosaminoglycan metabolic process [BP],
smooth muscle adaptation [BP],
mesenchymal cell proliferation involved in ureteric bud development [BP],
negative regulation of adiponectin secretion [BP],
positive regulation of calcidiol 1-monooxygenase activity [BP],
positive regulation of heterotypic cell-cell adhesion [BP],
glycosaminoglycan biosynthetic process [BP],
positive regulation of cell adhesion molecule production [BP],
peptidyl-dipeptidase inhibitor activity [MF],
positive regulation of monocyte chemotactic protein-1 production [BP],
monocyte aggregation [BP]
peptide-O-fucosyltransferase activity [MF],
myoblast differentiation [BP],
mesenchymal smoothened signaling pathway involved in prostate gland development [BP],
positive regulation of skeletal muscle cell proliferation [BP],
regulation of mesenchymal cell proliferation involved in prostate gland development [BP],
positive regulation of muscle cell differentiation [BP],
multicellular structure septum development [BP],
negative regulation of ureter smooth muscle cell differentiation [BP],
positive regulation of ureter smooth muscle cell differentiation [BP],
positive regulation of sclerotome development [BP],
positive regulation of kidney smooth muscle cell differentiation [BP]
calcium:sodium antiporter activity [MF]
metalloenzyme activator activity [MF]
positive regulation of DNA binding [BP],
nuclear membrane [CC],
histone deacetylase binding [MF],
protein complex assembly [BP],
positive regulation of viral transcription [BP],
positive regulation of gene expression [BP]
regulation of T cell homeostatic proliferation [BP],
early endosome to Golgi transport [BP],
bile-salt sulfotransferase activity [MF],
negative regulation of glomerular filtration by angiotensin [BP]
L-gulonate 3-dehydrogenase activity [MF],
thymine binding [MF],
uracil binding [MF]
microtubule-based peroxisome localization [BP]
auditory receptor cell fate commitment [BP],
Notch binding [MF]
viral penetration into host nucleus [BP],
negative regulation of RNA export from nucleus [BP],
nuclear pore nuclear basket [CC]
N-sulfoglucosamine sulfohydrolase activity [MF],
outer medullary collecting duct development [BP]
DNA-directed RNA polymerase II, core complex [CC]
aorta smooth muscle tissue morphogenesis [BP],
inner medullary collecting duct development [BP]
regulation of transcription from RNA polymerase II promoter involved in detection of glucose [BP],
negative regulation of detection of glucose [BP],
locomotory behavior [BP],
negative regulation of glucokinase activity [BP],
negative regulation of transcription from RNA polymerase II promoter by glucose [BP],
canonical Wnt receptor signaling pathway involved in metanephric kidney development [BP],
central nervous system myelin formation [BP],
positive regulation of transcription from RNA polymerase II promoter by glucose [BP]
inositol hexakisphosphate 6-kinase activity [MF],
acyl carnitine transmembrane transporter activity [MF]
corticosterone 18-monooxygenase activity [MF],
monooxygenase activity [MF],
regulation of blood volume by renal aldosterone [BP],
steroid 11-beta-monooxygenase activity [MF],
negative regulation of cellular organofluorine metabolic process [BP],
cellular water homeostasis [BP],
heme binding [MF],
iron ion binding [MF]
L-aminoadipate-semialdehyde dehydrogenase activity [MF]
alpha-1,6-mannosyltransferase activity [MF]
axial mesoderm formation [BP],
Wnt receptor signaling pathway involved in forebrain neuron fate commitment [BP],
carbohydrate mediated signaling [BP],
positive regulation of MAP kinase activity [BP],
olfactory placode formation [BP],
positive regulation of miRNA metabolic process [BP],
positive regulation of ruffle assembly [BP],
positive regulation of JNK cascade [BP],
positive regulation of GTPase activity [BP],
protein C-terminus binding [MF],
optic placode formation [BP]
3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [MF],
enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity [MF],
[acyl-carrier-protein] S-acetyltransferase activity [MF],
endothelial cell differentiation [BP],
3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [MF]
ethanolamine-phosphate cytidylyltransferase activity [MF]
Wnt receptor signaling pathway involved in forebrain neuron fate commitment [BP],
tryptophanyl-tRNA aminoacylation [BP],
cell adhesion molecule binding [MF],
beta-catenin binding [MF],
tryptophan-tRNA ligase activity [MF]
